POSA24 Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in Previously Untreated Advanced Melanoma: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.097
https://www.valueinhealthjournal.com/article/S1098-3015(21)01892-1/fulltext
Title :
POSA24 Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in Previously Untreated Advanced Melanoma: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01892-1&doi=10.1016/j.jval.2021.11.097
First page :
Section Title :
Open access? :
No
Section Order :
10611